NEW YORK, March 27 - Sequenom said Tuesday it has delivered MassArray systems for high-throughput SNP analysis to three new international customers: HiberGen of Wickow, Ireland; Korea Advanced Institute of Science and Technology (KAIST); and the National Cancer Center Research Institute in Japan.
"Our systems business continues to see demand for the MassArray platform, supported by influential early adopters such as the Sanger Centre, the Whitehead Institute and the National Institutes of Health," said Toni Schuh, Sequenom's CEO.
Sequenom said in a statement that it also sold a fourth system, although it did not disclose the name of the buyer.
Sequenom did not say how much the systems sold for, but in the past the company has said that the price of the MassArray is between $400,000 and $1.1 million depending on consumables.
In 2000, Sequenom placed 22 MassArray systems in seven different countries. So far this year, Sequenom has reported the sale of six systems.
HiberGen is a population genetics company that performs genotyping studies on the Irish population using its SNaPIT SNP analysis platform. KAIST and the National Cancer Research Institute are both publicly-funded research institutions performing genomics research.
The MassArray system, first commercialized in early 2000, provides a platform for genotyping experiments without the use of fluorescence or other tagging techniques. Instead, the company's technology applies MALDI-TOF mass spectrometry directly to fragments of DNA to detect SNPs.